What happens when a government agency in charge of assessing the effectiveness of medical interventions crunches numbers and tells pharmaceutical companies their drugs are just too expensive?

With a vision of offering the most robust drug information resources on the market, Wolters Kluwer Health has been bringing together the strongest clinical content and tools from its referential ...

Government funding is slated to boost comparative studies of prescription drugs. The economic stimulus package approved by Congress in February 2009 provides more than $1 billion to support research ...